Improved high-performance liquid chromatographic detection of paclitaxel in patient's plasma using solid-phase extraction, and semi-micro-bore C18 separation and UV detection

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 860, Issue 1, 2007, Pages 141-144

  Suno, Manabu ^a   Ono, Takashi ^a   Iida, Shinya ^a   Umetsu, Noriko ^a   Ohtaki, Ko ichi ^a   Yamada, Takehiro ^a   Awaya, Toshio ^a   Satomi, Machiko ^a   Tasaki, Yoshikazu ^a   Shimizu, Keiko ^a   Matsubara, Kazuo ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Docetaxel; HPLC UV; Paclitaxel; Semi micro bore column; Sep Pak C18; Therapeutic drug monitoring

Indexed keywords

DOCETAXEL; PACLITAXEL; THERAPEUTIC DRUG MONITORING;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ORGANIC CARBON; PATIENT MONITORING; SEPARATION; ULTRAVIOLET DETECTORS;

PLASMA (HUMAN);

BENZENE DERIVATIVE; DOCETAXEL; PACLITAXEL; PENTAFLUOROPHENYL; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LUNG NON SMALL CELL CANCER; OVARY CANCER; PATIENT SAFETY; PRIORITY JOURNAL; SEMI MICRO BORE COLUMN; SEP PAK C18 CARTRIDGE; SOLID PHASE EXTRACTION; ULTRAVIOLET SPECTROSCOPY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; FEMALE; HUMANS; PACLITAXEL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; ULTRAVIOLET RAYS;

EID: 36348943094     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2007.10.024     Document Type: Article

References (20)

1. Bunn P.A., and Kelly K. Clin. Cancer Res. 5 (1998) 1087
2. Schiller J.H., Harrington D., Belami C.P., Langer C., Sandler A., Krook J., Zhu J., and Johnson D.H. N. Engl. J. Med. 346 (2002) 92
3. Arbuck S.G., and Blaylock B.A. In: McGuire W.P., and Rowinsky E.K. (Eds). Paclitaxel in Cancer Treatment (1995), Marcel Dekker, New York 1
4. Maldonado V., De Anda J., and Meléndez-Zajgla J. J. Biochem. Toxicol. 11 (1996) 183
5. Torres K., and Horwitz S.B. Cancer Res. 58 (1998) 3620
6. Bishop J.F., Dewar J., Toner G.C., Smith J., Tattersall M.H., Olver I.N., Ackland S., Kennedy I., Goldstein D., Gurney H., Walpole E., Levi J., Stephenson J., and Canetta R. J. Clin. Oncol. 17 (1999) 2355
7. Trimble E.L., Adams J.D., Vena D., Hawkins M.J., Friedman M.A., Fisherman J.S., Christian M.C., Canetta R., Onetto N., Hayn R., and Arbuck S.G. J. Clin. Oncol. 11 (1993) 2405
8. Ohtsu T., Sasaki Y., Tamura T., Miyata Y., Nakanomyo H., Nishiwaki Y., and Saijo N. Clin. Cancer Res. 1 (1995) 559
9. Andersen A., Warren D.J., Brunsvig P.F., Aamdal S., Kristensen G.B., and Olsen H. BMC Clin. Pharmacol. 6 (2006) 2
10. Willey T.A., Bekos E.J., Gaver R.C., Duncan G.F., Tay L.K., Beijnen J.H., and Farmen R.H. J. Chromatogr. 621 (1993) 231
11. Sparreboom A., van Tellingen O., Nooijen W.J., and Beijnen J.H. J. Chromatogr. B 664 (1995) 383
12. Zufia Lopez L., Aldaz Pastor A., Aramendia Beitia J.M., Arrobas Velilla J., and Giraldez Deiro J. Ther. Drug Monit. (2006) 199
13. Parise R.A., Ramanathan R.K., Zamboni W.C., and Egorin M.J. J. Chromatogr. B 783 (2003) 231
14. Vainchtein L.D., Thijssen B., Stokvis E., Rosing H., Schellens J.H., and Beijnen J.H. Biomed. Chromatogr. 20 (2006) 139
15. Seidman A.D., Hudis C.A., Albanell J., Tong W., Tepler I., Currie V., Moynahan M.E., Theodoulou M., Gollub M., Baselga J., and Norton L. J. Clin. Oncol. 16 (1998) 3353
16. Supko J.G., Nair R.V., Seiden M.V., and Lu H. J. Pharm. Biomed. Anal. 21 (1999) 1025
17. Martin N., Catalin J., Blanchon M.F., and Durand A. J. Chromatogr. B 709 (1998) 281
18. Rowinsky E.K. Semin. Oncol. 6 Suppl. 19 (1997) S19
19. Henningsson A.H., Karlsson M.O., Vigano L., Gianni L., Verweij J., and Sparreboom A. J. Clin. Oncol. 19 (2001) 4065
20. Fogli S., Danesi R., De Braud F., De Pas T., Curigliano G., Giovannetti E., and Del Tacca M. Ann. Oncol. 12 (2001) 1553